ATE275151T1 - 3,6-ketal-makrolidantibiotika - Google Patents

3,6-ketal-makrolidantibiotika

Info

Publication number
ATE275151T1
ATE275151T1 AT99301325T AT99301325T ATE275151T1 AT E275151 T1 ATE275151 T1 AT E275151T1 AT 99301325 T AT99301325 T AT 99301325T AT 99301325 T AT99301325 T AT 99301325T AT E275151 T1 ATE275151 T1 AT E275151T1
Authority
AT
Austria
Prior art keywords
macrolida
ketal
antibiotic
macrolida antibiotic
ketal macrolida
Prior art date
Application number
AT99301325T
Other languages
English (en)
Inventor
Kristin M Lundy
Hengmiao Cheng
Subas M Sakya
Peter Bertinato
Martha L Minich
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE275151T1 publication Critical patent/ATE275151T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT99301325T 1998-03-03 1999-02-23 3,6-ketal-makrolidantibiotika ATE275151T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7663098P 1998-03-03 1998-03-03

Publications (1)

Publication Number Publication Date
ATE275151T1 true ATE275151T1 (de) 2004-09-15

Family

ID=22133253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99301325T ATE275151T1 (de) 1998-03-03 1999-02-23 3,6-ketal-makrolidantibiotika

Country Status (17)

Country Link
US (1) US6043226A (de)
EP (1) EP0941998B1 (de)
JP (1) JP3666788B2 (de)
CN (1) CN1244532A (de)
AR (1) AR016715A1 (de)
AT (1) ATE275151T1 (de)
AU (1) AU741435B2 (de)
BR (1) BR9900856A (de)
CA (1) CA2263203C (de)
DE (1) DE69919769T2 (de)
DK (1) DK0941998T3 (de)
ES (1) ES2226282T3 (de)
HU (1) HUP9900492A3 (de)
NO (1) NO312366B1 (de)
NZ (1) NZ334442A (de)
PT (1) PT941998E (de)
ZA (1) ZA991664B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
KR20010083944A (ko) * 1998-11-03 2001-09-03 실버스타인 아써 에이. 신규 마크롤라이드 항생물질
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
MXPA01010524A (es) 1999-04-16 2002-03-14 Kosan Biosciences Inc Agentes macrolidos anti-infecciosos.
US6514944B2 (en) * 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) * 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
EE200100613A (et) * 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
EP1146051A3 (de) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A-Derivate
JP2005502302A (ja) * 2000-11-07 2005-01-27 モーフオテク・インコーポレーテツド 超変異性哺乳動物細胞より新規抗微生物剤を単離するための方法
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US20060141470A1 (en) * 2003-02-14 2006-06-29 Kalayoglu Murat V Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
AP2007004026A0 (en) * 2004-12-21 2007-06-30 Pfizer Prod Inc Macrolides
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
JP5642548B2 (ja) * 2007-09-17 2014-12-17 エナンタ ファーマシューティカルズ インコーポレイテッド ６，１１−架橋ビアリールマクロライド
US11427606B2 (en) 2017-04-20 2022-08-30 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
CN110799516A (zh) * 2017-04-20 2020-02-14 来兴泰德基金会 作为抗癌剂的包含鏻离子的阿奇霉素衍生物
GB201706299D0 (en) * 2017-04-20 2017-06-07 Novintum Biotechnology Gmbh Compounds
WO2018193126A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as antibacterial agents
WO2018193116A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018193111A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018195446A1 (en) 2017-04-21 2018-10-25 Lisanti Michael P Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy
EP3612187B1 (de) 2017-04-21 2022-04-13 Lunella Biotech, Inc. Vitamin c und doxycyclin: eine synthetische letale kombinationstherapie zur eradikation von krebsstammzellen (cscs)
BR112019024264A2 (pt) 2017-05-19 2020-06-02 Lunella Biotech, Inc. Antimitoscinas: inibidores direcionados da biogênese mitoconcrial para erradicação de células-tronco de câncer
MX2019014806A (es) 2017-06-26 2020-02-10 Lunella Biotech Inc Mitocetoscinas: agentes terapeuticos basados en mitocondrias que fijan como objetivo el metabolismo de cetonas en celulas cancerosas.
GB201817083D0 (en) * 2018-10-19 2018-12-05 Novintum Biotechnology Gmbh Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8721165D0 (en) * 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
EP0344106A3 (de) * 1988-05-24 1990-01-31 Ciba-Geigy Ag Blaue Dispersionsfarbstoffe und Mischungen blauer Dispersionsfarbstoffe
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
CA2154550A1 (en) * 1993-01-26 1994-08-04 Yoko Misawa 5-o-desosaminylerythronolide derivatives
EP0918783A1 (de) * 1996-05-07 1999-06-02 Abbott Laboratories 6-0-substituierte erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0941998B1 (de) 2004-09-01
JP3666788B2 (ja) 2005-06-29
BR9900856A (pt) 2000-04-25
EP0941998A2 (de) 1999-09-15
ZA991664B (en) 2000-10-12
US6043226A (en) 2000-03-28
ES2226282T3 (es) 2005-03-16
DK0941998T3 (da) 2004-09-20
JPH11315093A (ja) 1999-11-16
HU9900492D0 (en) 1999-04-28
HUP9900492A2 (hu) 1999-09-28
HUP9900492A3 (en) 2001-08-28
CA2263203A1 (en) 1999-09-03
NZ334442A (en) 2000-03-27
AU1856299A (en) 1999-09-16
PT941998E (pt) 2004-12-31
NO991012L (no) 1999-09-06
DE69919769D1 (de) 2004-10-07
NO991012D0 (no) 1999-03-02
AU741435B2 (en) 2001-11-29
AR016715A1 (es) 2001-07-25
CA2263203C (en) 2002-09-03
EP0941998A3 (de) 1999-10-06
CN1244532A (zh) 2000-02-16
DE69919769T2 (de) 2005-01-27
NO312366B1 (no) 2002-04-29

Similar Documents

Publication Publication Date Title
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
ATE322910T1 (de) Neuartige antibiotika
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
CU23049A3 (es) Dihidropirimidinas.
IS5528A (is) Ný makrólíð
DE69838651D1 (de) Erythromycinderivate
DE69902762D1 (de) Riser-spannanordnung
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
ID27775A (id) Antibiotik-antibiotik nokatiasin
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DK1149106T3 (da) 4,5-azolo-oxindoler
ID27686A (id) Turunan 3-(2-okso-[1,3]bipirolidinil-3-ildenametil)-sefem
ID26368A (id) Turunan-turunan 2 deoksi higromisin
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
DE59909590D1 (de) Azidfreie, gaserzeugende zusammensetzung
ES1040633Y (es) Escalifono.
ES1040589Y (es) Expositor-dispensador.
ES1040731Y (es) Gafa.
ES1040343Y (es) Carrito portafregona.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0941998

Country of ref document: EP

REN Ceased due to non-payment of the annual fee